Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Acute Myeloid Leukemia industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sunesis Pharmaceuticals Inc
Celegene Corporation
Pfizer Inc
Genmab AS
Bristol-Myers Squibb Company
Eisai Co Ltd
Teva Pharmaceutical (Cephalon Inc)
Novartis AG
By Type:
Anti-metabolites
Hormonal Therapy
Tyrosine Kinase Inhibitors
Cytarabine
Other Chemotherapies
Anthracycline Drugs
Alkylating Agents
By Application:
Hospital
Retails Drug Stores
Clinics
Ambulatory Care Centers
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Acute Myeloid Leukemia Market Overview 2018-2029
-
1.1 China Acute Myeloid Leukemia Industry Development Overview
-
1.2 China Acute Myeloid Leukemia Industry Development History
-
1.3 China Acute Myeloid Leukemia Industry Market Size (2018-2029)
-
1.4 China Acute Myeloid Leukemia Market Analysis by Type from Production Side
-
1.4.1 China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Anti-metabolites (2018-2029)
-
1.4.2 China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)
-
1.4.3 China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Tyrosine Kinase Inhibitors (2018-2029)
-
1.4.4 China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Cytarabine (2018-2029)
-
1.4.5 China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Other Chemotherapies (2018-2029)
-
1.4.6 China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Anthracycline Drugs (2018-2029)
-
1.4.7 China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Alkylating Agents (2018-2029)
-
1.5 China Acute Myeloid Leukemia Market Analysis by Application from Consumption End
-
1.5.1 China Acute Myeloid Leukemia Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Acute Myeloid Leukemia Sales Volume, Sales Value and Growth Rate of Retails Drug Stores (2018-2029)
-
1.5.3 China Acute Myeloid Leukemia Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.5.4 China Acute Myeloid Leukemia Sales Volume, Sales Value and Growth Rate of Ambulatory Care Centers (2018-2029)
-
1.6 China Acute Myeloid Leukemia Market Analysis by Region
-
1.6.1 North China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
Chapter 2 China Acute Myeloid Leukemia Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Acute Myeloid Leukemia Market Status and Competition at home and abroad in 2023
-
2.2.2 China Acute Myeloid Leukemia Market Status and Competition Analysis in 2023
-
2.2.3 China Acute Myeloid Leukemia Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Acute Myeloid Leukemia Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Acute Myeloid Leukemia Industry Development
Chapter 3 Acute Myeloid LeukemiaIndustry Chain Analysis
-
3.1 Acute Myeloid Leukemia Industry Chain
-
3.2 Acute Myeloid Leukemia Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Acute Myeloid Leukemia Market
-
3.3 Acute Myeloid Leukemia Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Acute Myeloid Leukemia Market
Chapter 4 China Acute Myeloid Leukemia Market, by Type
-
4.1 China Acute Myeloid Leukemia Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Acute Myeloid Leukemia Total Production Volume and Growth Rate from Production Side
-
4.5 China Acute Myeloid Leukemia Production Volume and Growth Rate, by Type
-
4.5.1 China Acute Myeloid Leukemia Production Volume and Growth Rate of Anti-metabolites
-
4.5.2 China Acute Myeloid Leukemia Production Volume and Growth Rate of Hormonal Therapy
-
4.5.3 China Acute Myeloid Leukemia Production Volume and Growth Rate of Tyrosine Kinase Inhibitors
-
4.5.4 China Acute Myeloid Leukemia Production Volume and Growth Rate of Cytarabine
-
4.5.5 China Acute Myeloid Leukemia Production Volume and Growth Rate of Other Chemotherapies
-
4.5.6 China Acute Myeloid Leukemia Production Volume and Growth Rate of Anthracycline Drugs
-
4.5.7 China Acute Myeloid Leukemia Production Volume and Growth Rate of Alkylating Agents
Chapter 5 China Acute Myeloid Leukemia Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Acute Myeloid Leukemia Total Market Size and Growth Rate from Consumption End
-
5.5 China Acute Myeloid Leukemia Market Size and Growth Rate, by Application
-
5.5.1 China Acute Myeloid Leukemia Market Size and Growth Rate of Hospital
-
5.5.2 China Acute Myeloid Leukemia Market Size and Growth Rate of Retails Drug Stores
-
5.5.3 China Acute Myeloid Leukemia Market Size and Growth Rate of Clinics
-
5.5.4 China Acute Myeloid Leukemia Market Size and Growth Rate of Ambulatory Care Centers
Chapter 6 China Acute Myeloid Leukemia Market, by Region
-
6.1 China Acute Myeloid Leukemia Production Volume and Production Value, by Region
-
6.2 China Acute Myeloid Leukemia Sales Volume and Sales Value, by Region
Chapter 7 North China Acute Myeloid Leukemia Market Analysis
-
7.1 North China Acute Myeloid Leukemia Market, by Type
-
7.2 North China Acute Myeloid Leukemia Market, by Application
Chapter 8 Central China Acute Myeloid Leukemia Market Analysis
-
8.1 Central China Acute Myeloid Leukemia Market, by Type
-
8.2 Central China Acute Myeloid Leukemia Market, by Application
Chapter 9 South China Acute Myeloid Leukemia Market Analysis
-
9.1 South China Acute Myeloid Leukemia Market, by Type
-
9.2 South China Acute Myeloid Leukemia Market, by Application
Chapter 10 East China Acute Myeloid Leukemia Market Analysis
-
10.1 East China Acute Myeloid Leukemia Market, by Type
-
10.2 East China Acute Myeloid Leukemia Market, by Application
Chapter 11 Northeast China Acute Myeloid Leukemia Market Analysis
-
11.1 Northeast China Acute Myeloid Leukemia Market, by Type
-
11.2 Northeast China Acute Myeloid Leukemia Market, by Application
Chapter 12 Southwest China Acute Myeloid Leukemia Market Analysis
-
12.1 Southwest China Acute Myeloid Leukemia Market, by Type
-
12.2 Southwest China Acute Myeloid Leukemia Market, by Application
Chapter 13 Northwest China Acute Myeloid Leukemia Market Analysis
-
13.1 Northwest China Acute Myeloid Leukemia Market, by Type
-
13.2 Northwest China Acute Myeloid Leukemia Market, by Application
Chapter 14 Company Profiles
-
14.1 Sunesis Pharmaceuticals Inc
-
14.1.1 Sunesis Pharmaceuticals Inc Company Profile
-
14.1.2 Sunesis Pharmaceuticals Inc Acute Myeloid Leukemia Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Celegene Corporation
-
14.2.1 Celegene Corporation Company Profile
-
14.2.2 Celegene Corporation Acute Myeloid Leukemia Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Profile
-
14.3.2 Pfizer Inc Acute Myeloid Leukemia Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Genmab AS
-
14.4.1 Genmab AS Company Profile
-
14.4.2 Genmab AS Acute Myeloid Leukemia Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bristol-Myers Squibb Company
-
14.5.1 Bristol-Myers Squibb Company Company Profile
-
14.5.2 Bristol-Myers Squibb Company Acute Myeloid Leukemia Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Eisai Co Ltd
-
14.6.1 Eisai Co Ltd Company Profile
-
14.6.2 Eisai Co Ltd Acute Myeloid Leukemia Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Teva Pharmaceutical (Cephalon Inc)
-
14.7.1 Teva Pharmaceutical (Cephalon Inc) Company Profile
-
14.7.2 Teva Pharmaceutical (Cephalon Inc) Acute Myeloid Leukemia Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Novartis AG
-
14.8.1 Novartis AG Company Profile
-
14.8.2 Novartis AG Acute Myeloid Leukemia Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Acute Myeloid Leukemia Industry Research Conclusions
-
15.2 Acute Myeloid Leukemia Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Acute Myeloid Leukemia Industry Market Size (2018-2029)
-
Figure China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Anti-metabolites (2018-2029)
-
Figure China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)
-
Figure China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Tyrosine Kinase Inhibitors (2018-2029)
-
Figure China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Cytarabine (2018-2029)
-
Figure China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Other Chemotherapies (2018-2029)
-
Figure China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Anthracycline Drugs (2018-2029)
-
Figure China Acute Myeloid Leukemia Production Volume, Production Value and Growth Rate of Alkylating Agents (2018-2029)
-
Figure China Acute Myeloid Leukemia Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Acute Myeloid Leukemia Sales Volume, Sales Value and Growth Rate of Retails Drug Stores (2018-2029)
-
Figure China Acute Myeloid Leukemia Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure China Acute Myeloid Leukemia Sales Volume, Sales Value and Growth Rate of Ambulatory Care Centers (2018-2029)
-
Figure North China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
Figure Central China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
Figure South China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
Figure East China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Acute Myeloid Leukemia Market Size and Growth Rate from 2018-2029
-
Figure Acute Myeloid Leukemia Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Acute Myeloid Leukemia Market Share by Type in 2018
-
Figure China Acute Myeloid Leukemia Market Share by Type in 2023
-
Figure China Acute Myeloid Leukemia Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Volume and Growth Rate of Anti-metabolites (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Volume and Growth Rate of Hormonal Therapy (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Volume and Growth Rate of Tyrosine Kinase Inhibitors (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Volume and Growth Rate of Cytarabine (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Volume and Growth Rate of Other Chemotherapies (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Volume and Growth Rate of Anthracycline Drugs (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Volume and Growth Rate of Alkylating Agents (2018-2023)
-
Figure China Acute Myeloid Leukemia Market Share by Application in 2018
-
Figure China Acute Myeloid Leukemia Market Share by Application in 2023
-
Figure China Acute Myeloid Leukemia Total Market Size and Growth Rate from Consumption End
-
Figure China Acute Myeloid Leukemia Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Acute Myeloid Leukemia Market Size and Growth Rate of Retails Drug Stores (2018-2023)
-
Figure China Acute Myeloid Leukemia Market Size and Growth Rate of Clinics (2018-2023)
-
Figure China Acute Myeloid Leukemia Market Size and Growth Rate of Ambulatory Care Centers (2018-2023)
-
Table China Acute Myeloid Leukemia Production Volume by Region (2018-2023)
-
Table China Acute Myeloid Leukemia Production Volume Share by Region (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Volume Share by Region (2018-2023)
-
Table China Acute Myeloid Leukemia Production Value by Region (2018-2023)
-
Table China Acute Myeloid Leukemia Production Value Share by Region (2018-2023)
-
Figure China Acute Myeloid Leukemia Production Value Share by Region (2018-2023)
-
Table China Acute Myeloid Leukemia Sales Volume by Region (2018-2023)
-
Table China Acute Myeloid Leukemia Sales Volume Share by Region (2018-2023)
-
Figure China Acute Myeloid Leukemia Sales Volume Share by Region (2018-2023)
-
Table China Acute Myeloid Leukemia Sales Value by Region (2018-2023)
-
Table China Acute Myeloid Leukemia Sales Value Share by Region (2018-2023)
-
Figure China Acute Myeloid Leukemia Sales Value Share by Region (2018-2023)
-
Table North China Acute Myeloid Leukemia Production Volume by Type (2018-2023)
-
Table North China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Figure North China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Table North China Acute Myeloid Leukemia Sales Volume by Application (2018-2023)
-
Table North China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Figure North China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Table Central China Acute Myeloid Leukemia Production Volume by Type (2018-2023)
-
Table Central China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Figure Central China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Table Central China Acute Myeloid Leukemia Sales Volume by Application (2018-2023)
-
Table Central China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Figure Central China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Table South China Acute Myeloid Leukemia Production Volume by Type (2018-2023)
-
Table South China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Figure South China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Table South China Acute Myeloid Leukemia Sales Volume by Application (2018-2023)
-
Table South China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Figure South China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Table East China Acute Myeloid Leukemia Production Volume by Type (2018-2023)
-
Table East China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Figure East China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Table East China Acute Myeloid Leukemia Sales Volume by Application (2018-2023)
-
Table East China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Figure East China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Table Northeast China Acute Myeloid Leukemia Production Volume by Type (2018-2023)
-
Table Northeast China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Figure Northeast China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Table Northeast China Acute Myeloid Leukemia Sales Volume by Application (2018-2023)
-
Table Northeast China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Table Southwest China Acute Myeloid Leukemia Production Volume by Type (2018-2023)
-
Table Southwest China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Figure Southwest China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Table Southwest China Acute Myeloid Leukemia Sales Volume by Application (2018-2023)
-
Table Southwest China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Table Northwest China Acute Myeloid Leukemia Production Volume by Type (2018-2023)
-
Table Northwest China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Figure Northwest China Acute Myeloid Leukemia Production Volume Share by Type (2018-2023)
-
Table Northwest China Acute Myeloid Leukemia Sales Volume by Application (2018-2023)
-
Table Northwest China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Acute Myeloid Leukemia Sales Volume Share by Application (2018-2023)
-
Table Sunesis Pharmaceuticals Inc Company Profile
-
Table Sunesis Pharmaceuticals Inc Acute Myeloid Leukemia Revenue, Price and Gross (2018-2023)
-
Table Celegene Corporation Company Profile
-
Table Celegene Corporation Acute Myeloid Leukemia Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Acute Myeloid Leukemia Revenue, Price and Gross (2018-2023)
-
Table Genmab AS Company Profile
-
Table Genmab AS Acute Myeloid Leukemia Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Company Profile
-
Table Bristol-Myers Squibb Company Acute Myeloid Leukemia Revenue, Price and Gross (2018-2023)
-
Table Eisai Co Ltd Company Profile
-
Table Eisai Co Ltd Acute Myeloid Leukemia Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical (Cephalon Inc) Company Profile
-
Table Teva Pharmaceutical (Cephalon Inc) Acute Myeloid Leukemia Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Acute Myeloid Leukemia Revenue, Price and Gross (2018-2023)
-
